1. The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activation. Issue 3 (15th March 2022) Authors: Sum, Eva; Rapp, Moritz; Dürr, Harald; Mazumdar, Alekhya; Romero, Pedro J; Trumpfheller, Christine; Umaña, Pablo Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗